HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morphological change by overexpression of D385A dominant negative presenilin 1 in human neuroblastoma SH-SY5Y cells.

Abstract
Presenilin 1 (PS1) is a multifunctional protein, and its mutations are highly related to familial Alzheimer's disease (AD). In this study, we examined the effects of PS1 overexpression on neuronal morphology using SH-SY5Y cells. Overexpression of dominant-negative D385A PS1 induced morphological change and impairment of neurite formation, while those of wild-type and pathogenic P117L mutant PS1 did not change cellular morphology compared with native cells. Moreover, filopodium-formation-related proteins were decreased only in cells overexpressing D385A PS1. Therefore, PS1 may be involved in neuritogenesis and morphological change in SH-SY5Y cells, and P117L mutation may linked to AD by different mechanisms.
AuthorsDaiju Tsuchiya, Yoshihisa Kitamura, Kazuyuki Takata, Takashi Taniguchi, Kengo Uemura, Hiroaki Miki, Tadaomi Takenawa, Shun Shimohama
JournalJournal of pharmacological sciences (J Pharmacol Sci) Vol. 102 Issue 3 Pg. 354-8 (Nov 2006) ISSN: 1347-8613 [Print] Japan
PMID17099291 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Presenilin-1
Topics
  • Brain Neoplasms (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Humans
  • Immunoblotting
  • Mutation (physiology)
  • Neurites (physiology, ultrastructure)
  • Neuroblastoma (genetics, metabolism, pathology)
  • Presenilin-1 (biosynthesis, genetics)
  • Pseudopodia (physiology, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: